BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:34 PM
 | 
Oct 23, 2009
 |  BC Extra  |  Company News

FDA posts ABthrax briefing documents

FDA posted briefing documents ahead of Tuesday's Anti-Infective Drugs Advisory Committee meeting to discuss a BLA from Human Genome Sciences Inc. (NASDAQ:HGSI) for ABthrax raxibacumab to treat inhalation anthrax. The panel will be asked whether pivotal animal studies support that ABthrax...

Read the full 205 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >